EW Healthcare Partners, L.P. - Aug 30, 2023 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Signature
EW Healthcare Partners, L.P.; By Essex Woodlands Fund IX-GP, L.P., its General Partner; By Essex Woodlands IX, LLC, its General Partner; By Ronald Eastman, Manager; By Gregory L. Hill, Attorney-in-Fact, /s/Gregory L. Hill
Stock symbol
EYPT
Transactions as of
Aug 30, 2023
Transactions value $
-$1,470,208
Form type
4
Date filed
9/1/2023, 04:51 PM
Previous filing
Aug 30, 2023
Next filing
Sep 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock, $0.001 par value Sale -$662K -60.6K -1.66% $10.92 3.59M Aug 30, 2023 See Footnotes F1, F2, F6
transaction EYPT Common Stock, $0.001 par value Sale -$3.71K -327 -0.01% $11.36 3.59M Aug 30, 2023 See Footnotes F1, F3, F6
transaction EYPT Common Stock, $0.001 par value Sale -$727K -71.5K -1.99% $10.17 3.52M Aug 31, 2023 See Footnotes F1, F4, F6
transaction EYPT Common Stock, $0.001 par value Sale -$77.3K -7.02K -0.2% $11.02 3.51M Aug 31, 2023 See Footnotes F1, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 58,616 shares and 75,457 shares of the amounts shown above on August 30, 2023 and August 31, 2023, respectively, and EWHP-A sold 2,360 shares and 3,038 shares of the amounts shown above on August 30, 2023 and August 31, 2023, respectively. EWHP now holds a total of 3,375,147 shares of Common Stock of the Issuer and EWHP-A now holds a total of 135,774 shares of Common Stock of the Issuer.
F2 Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.32 to $11.29. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3 Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $11.35 to $11.37. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4 Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $9.83 to $10.76. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F5 Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.84 to $11.23. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F6 Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EWHP Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Fund IX GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.